The global immunotoxins market share analysis is poised for significant growth, with its valuation expected to reach USD 159.2 million by 2025 and further expand to USD 410.2 million by 2035, at a CAGR of 4.3% during the forecast period. Immunotoxins represent a breakthrough in targeted therapeutics, particularly in oncology, combining the precision of monoclonal …